Posts tagged as: dna therapy back to homepage
 |
Cardium and Generx Featured on San Diego Biotechnology Connection(0) An article this morning on San Diego Biotechnology Connection website, discusses an important breakthrough in technology and regenerative medicine. The article provides details of Cardium Therapeutics (NYSE MKT: CXM) and its Generx product candidate, a DNA-based angiogenic growth factor therapeutic being developed for the potential treatment of patients with advanced coronary artery disease. The article titled, “Cardium Therapeutics reports advance – gene therapy process technology” was written by Rex Graham, a science journalist with a master’s degree in microbiology and a 30-year career Read More |
 |
Cardium Therapeutics Presents at Marcum MicroCap Conference 2012 Video(0) Christopher J. Reinhard, Chairman & CEO presented at the Marcum MicroCap Conference on June 20, 2012 at at the Roosevelt Hotel in New York City. In the presentation, Mr. Reinhard details Cardium products, including Generx as a product candidate for advanced coronary artery disease, Excellagen for wound care management and the company’s line of MedPodium neutraceuticals,metabolics and aesthetics. Read More |
OTCBB News
read more
Stay Informed
Dana-Farber to Host Cellceutix Trials
Diabetes Rate Growing Exponentially
According to the International Diabetes Federation, more than 500 million people will be diagnosed with diabetes in the next two decades, a more than 50 percent increase from today. Technologies are available presently to help manage the frequency, complications and costs associated with diabetes. Read the complete article to learn more.
